Structure-Guided Redesign of RBD-Specific Antibodies to ImproveBinding Affinity to SARS-CoV-2 Sublineages

Authors

Institutions

Publication Details

Journal
Current Topics in Medicinal Chemistry
Published
2026-03-11
DOI
https://doi.org/10.2174/0115680266434732251229070155
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Structure-Guided Redesign of RBD-Specific Antibodies to ImproveBinding Affinity to SARS-CoV-2 Sublineages

Jair Pereira da Cunha-Júnior, Carlos Roberto Prudêncio, Nilson Nicolau-Júnior, VICTOR HUGO OLIVEIRA DE ANDRADE et al.
Current Topics in Medicinal Chemistry
SARS-CoV-2 and COVID-19 Research
article

Structure-Guided Redesign of RBD-Specific Antibodies to ImproveBinding Affinity to SARS-CoV-2 Sublineages

Jair Pereira da Cunha-Júnior, Carlos Roberto Prudêncio, Nilson Nicolau-Júnior, VICTOR HUGO OLIVEIRA DE ANDRADE, Daniel Ferreira de Lima Neto, Cecília Luiza Pereira
article en

Abstract

No abstract available for this paper.
Current Topics in Medicinal ChemistryVol. 26
Instituto Adolfo Lutz (BR), Ministério da Saúde (BR), Universidade Federal de Uberlândia (BR)
Openalex Percentile: Top 27%
SARS-CoV-2 and COVID-19 Research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.